Skip to main content
Top
Published in: Pathology & Oncology Research 3/2018

01-07-2018 | Original Article

Identification of Potential Gene Network Associated with HCV-Related Hepatocellular Carcinoma Using Microarray Analysis

Authors: Yang Cheng, Jian Ping, Jianjie Chen

Published in: Pathology & Oncology Research | Issue 3/2018

Login to get access

Abstract

In order to identify potential specific gene networks of Hepatitis C virus (HCV) related hepatocellular carcinoma (HCC), weighted gene co-expression network analysis (WGCNA) was performed, which may provide an insight into the potential mechanism of the HCC development. HCV-related HCC and normal sample data were downloaded from GEO, T test of limma package was used to screen different expression genes (DEGs); KEGG pathway was used to analyze related biochemical pathways, and WGCNA was used to construct clustering trees and screen hub genes in the HCC-specific modules. A total of 1151 DEGs were authenticated between the HCC and normal liver tissue samples, including 433 upregulated and 718 downregulated genes. Among these genes, three specific modules of HCC were constructed, including Tan, Yellow and Cyan, but only Yellow module had a significant enrichment score in substance combination module with three hub genes: SLA2547, EFNA4 and MME. Although Tan and Cyan separately had four and three hub genes, but the bio-functions of them did not have significant enrichment scores (score < 2). SLA2547, EFNA4 and MME may play important roles in the substance combination of HCV-related HCC, so studying the function of this gene network may provide us a deeper understanding of HCV-related HCC.
Literature
1.
go back to reference Jin B, Wang W, Du G, Huang GZ, Han LT, Tang ZY et al (2015) Identifying hub genes and dysregulated pathways in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci 19:592–601PubMed Jin B, Wang W, Du G, Huang GZ, Han LT, Tang ZY et al (2015) Identifying hub genes and dysregulated pathways in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci 19:592–601PubMed
3.
go back to reference Castello G, Scala S, Palmieri G, Curley SA, Izzo F (2010) HCV-related hepatocellular carcinoma: from chronic inflammation to cancer. Clin Immunol 134:237–250CrossRefPubMed Castello G, Scala S, Palmieri G, Curley SA, Izzo F (2010) HCV-related hepatocellular carcinoma: from chronic inflammation to cancer. Clin Immunol 134:237–250CrossRefPubMed
4.
go back to reference Petrizzo A, Caruso FP, Tagliamonte M, Tornesello ML, Ceccarelli M, Costa V et al (2016) Identification and validation of HCC-specific Gene transcriptional signature for tumor antigen discovery. Sci Rep 6:29258CrossRefPubMedPubMedCentral Petrizzo A, Caruso FP, Tagliamonte M, Tornesello ML, Ceccarelli M, Costa V et al (2016) Identification and validation of HCC-specific Gene transcriptional signature for tumor antigen discovery. Sci Rep 6:29258CrossRefPubMedPubMedCentral
5.
go back to reference Kakehashi A, Ishii N, Sugihara E, Min G, Saya H, Wanibuchi H (2016) CD44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virus-positive patients with resected hepatocellular carcinoma. Cancer Sci 107:609–618CrossRefPubMedPubMedCentral Kakehashi A, Ishii N, Sugihara E, Min G, Saya H, Wanibuchi H (2016) CD44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virus-positive patients with resected hepatocellular carcinoma. Cancer Sci 107:609–618CrossRefPubMedPubMedCentral
6.
go back to reference Boj S, Vanes J, Huch M, Li VW, José A, Hatzis P et al (2012) Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand. Cell 151:1595–1607CrossRefPubMed Boj S, Vanes J, Huch M, Li VW, José A, Hatzis P et al (2012) Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand. Cell 151:1595–1607CrossRefPubMed
9.
go back to reference Lambert MP, Paliwal A, Vaissière T, Chemin I, Zoulim F, Tommasino M et al (2011) Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. J Hepatol 54:705–715CrossRefPubMed Lambert MP, Paliwal A, Vaissière T, Chemin I, Zoulim F, Tommasino M et al (2011) Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. J Hepatol 54:705–715CrossRefPubMed
10.
go back to reference Hodo Y, Honda M, Tanaka A, Nomura Y, Arai K, Yamashita T et al (2013) Association of interleukin-28B genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis C. Clin Cancer Res 19:1827–1837CrossRefPubMed Hodo Y, Honda M, Tanaka A, Nomura Y, Arai K, Yamashita T et al (2013) Association of interleukin-28B genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis C. Clin Cancer Res 19:1827–1837CrossRefPubMed
11.
go back to reference Zhang J, Baddoo M, Han C, Strong MJ, Cvitanovic J, Moroz K et al (2016) Gene network analysis reveals a novel 22-gene signature of carbon metabolism in hepatocellular carcinoma. Oncotarget 7:49232–49245PubMedPubMedCentral Zhang J, Baddoo M, Han C, Strong MJ, Cvitanovic J, Moroz K et al (2016) Gene network analysis reveals a novel 22-gene signature of carbon metabolism in hepatocellular carcinoma. Oncotarget 7:49232–49245PubMedPubMedCentral
12.
go back to reference Xu Y, Cui J, Puett D (2014) Understanding cancer invasion and metastasis. Springer, New YorkCrossRef Xu Y, Cui J, Puett D (2014) Understanding cancer invasion and metastasis. Springer, New YorkCrossRef
13.
go back to reference Ueda T, Honda M, Horimoto K, Aburatani S, Saito S, Yamashita T et al (2013) Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling ☆. Genomics 101:238–248CrossRefPubMed Ueda T, Honda M, Horimoto K, Aburatani S, Saito S, Yamashita T et al (2013) Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling ☆. Genomics 101:238–248CrossRefPubMed
14.
go back to reference † SC, † PSS, Lee J, Park J, Shin EC, Choi C (2015) Prolonged silencing of diacylglycerol acyltransferase-1 induces a dedifferentiated phenotype in human liver cells. J Cell Mol Med 20:38–47 † SC, † PSS, Lee J, Park J, Shin EC, Choi C (2015) Prolonged silencing of diacylglycerol acyltransferase-1 induces a dedifferentiated phenotype in human liver cells. J Cell Mol Med 20:38–47
15.
go back to reference Irizarry RA, Hobbs B, Collin F, Beazerbarclay YD, Antonellis KJ, Scherf U et al (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249–264CrossRefPubMed Irizarry RA, Hobbs B, Collin F, Beazerbarclay YD, Antonellis KJ, Scherf U et al (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249–264CrossRefPubMed
16.
go back to reference Diboun I, Wernisch L, Orengo CA, Koltzenburg M (2006) Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics 7:1–14CrossRef Diboun I, Wernisch L, Orengo CA, Koltzenburg M (2006) Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics 7:1–14CrossRef
17.
18.
go back to reference Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocol 4:44–57CrossRef Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocol 4:44–57CrossRef
19.
go back to reference Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinf 9:1–13CrossRef Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinf 9:1–13CrossRef
20.
go back to reference Bushkofsky JR, Maguire M, Larsen MC, Fong YH, Jefcoate CR (2016) Cyp1b1 affects external control of mouse hepatocytes, fatty acid homeostasis and signaling involving HNF4α and PPARα. Arch Biochem Biophys 597:30–47CrossRefPubMedPubMedCentral Bushkofsky JR, Maguire M, Larsen MC, Fong YH, Jefcoate CR (2016) Cyp1b1 affects external control of mouse hepatocytes, fatty acid homeostasis and signaling involving HNF4α and PPARα. Arch Biochem Biophys 597:30–47CrossRefPubMedPubMedCentral
21.
go back to reference Lamming DW, Demirkan G, Boylan JM, Mihaylova MM, Peng T, Ferreira J et al (2014) Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2). Faseb Journal Official Publication of the Federation of American Societies for Experimental Biology 28:300–315CrossRefPubMedPubMedCentral Lamming DW, Demirkan G, Boylan JM, Mihaylova MM, Peng T, Ferreira J et al (2014) Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2). Faseb Journal Official Publication of the Federation of American Societies for Experimental Biology 28:300–315CrossRefPubMedPubMedCentral
22.
go back to reference Archer KJ, Mas VR, Maluf DG, Fisher RA (2010) High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma. Molecular Genetics & Genomics Mgg 283:341–349CrossRefPubMed Archer KJ, Mas VR, Maluf DG, Fisher RA (2010) High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma. Molecular Genetics & Genomics Mgg 283:341–349CrossRefPubMed
23.
go back to reference Tong J, Xie J, Ren H, Liu J, Zhang W, Wei C et al (2015) Comparison of glomerular Transcriptome profiles of adult-onset steroid sensitive focal segmental Glomerulosclerosis and minimal change disease. PLoS One 10:e0140453CrossRefPubMedPubMedCentral Tong J, Xie J, Ren H, Liu J, Zhang W, Wei C et al (2015) Comparison of glomerular Transcriptome profiles of adult-onset steroid sensitive focal segmental Glomerulosclerosis and minimal change disease. PLoS One 10:e0140453CrossRefPubMedPubMedCentral
24.
go back to reference Arvanitis DN, Davy A (1900) Regulation and misregulation of Eph/ephrin expression. Cell Adhes Migr 6:131–137CrossRef Arvanitis DN, Davy A (1900) Regulation and misregulation of Eph/ephrin expression. Cell Adhes Migr 6:131–137CrossRef
25.
go back to reference Saintigny P, Peng S, Zhang L, Sen B, Wistuba II, Lippman SM et al (2012) Global evaluation of Eph receptors and Ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion. Mol Cancer Ther 11:2021–2032CrossRefPubMedPubMedCentral Saintigny P, Peng S, Zhang L, Sen B, Wistuba II, Lippman SM et al (2012) Global evaluation of Eph receptors and Ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion. Mol Cancer Ther 11:2021–2032CrossRefPubMedPubMedCentral
26.
go back to reference Abdou AG, Abd el-Wahed MM, Asaad NY, Samaka RM, Abdallaha R (2010) Ephrin A4 expression in osteosarcoma, impact on prognosis, and patient outcome. Indian J Cancer 47:46–52CrossRefPubMed Abdou AG, Abd el-Wahed MM, Asaad NY, Samaka RM, Abdallaha R (2010) Ephrin A4 expression in osteosarcoma, impact on prognosis, and patient outcome. Indian J Cancer 47:46–52CrossRefPubMed
27.
go back to reference Hernaez R (2011) Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: a narrative review. Gastroenterol Hepatol 35:32–41CrossRefPubMed Hernaez R (2011) Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: a narrative review. Gastroenterol Hepatol 35:32–41CrossRefPubMed
28.
go back to reference Sanchez-Antolín G, Almohalla-Alvarez C, Bueno P, Almansa R, Iglesias V, Rico L et al (2015) Evidence of active pro-fibrotic response in blood of patients with cirrhosis. PLoS One 10:e0137128CrossRefPubMedPubMedCentral Sanchez-Antolín G, Almohalla-Alvarez C, Bueno P, Almansa R, Iglesias V, Rico L et al (2015) Evidence of active pro-fibrotic response in blood of patients with cirrhosis. PLoS One 10:e0137128CrossRefPubMedPubMedCentral
29.
go back to reference English DP, Santin AD (2012) Claudins overexpression in ovarian cancer: potential targets for Clostridium perfringens enterotoxin (CPE) based diagnosis and therapy. Int J Mol Sci 14:10412–10437CrossRef English DP, Santin AD (2012) Claudins overexpression in ovarian cancer: potential targets for Clostridium perfringens enterotoxin (CPE) based diagnosis and therapy. Int J Mol Sci 14:10412–10437CrossRef
30.
go back to reference Lin H, Liu W, Fang Z, Liang X, Li J, Bai Y et al (2015) Overexpression of DHX32 contributes to the growth and metastasis of colorectal cancer. Sci Rep 5:9247CrossRefPubMedPubMedCentral Lin H, Liu W, Fang Z, Liang X, Li J, Bai Y et al (2015) Overexpression of DHX32 contributes to the growth and metastasis of colorectal cancer. Sci Rep 5:9247CrossRefPubMedPubMedCentral
31.
go back to reference Kim KH, Lee MS (2014) Autophagy - a key player in cellular and body metabolism. Nat Rev Endocrinol 10:322–337CrossRefPubMed Kim KH, Lee MS (2014) Autophagy - a key player in cellular and body metabolism. Nat Rev Endocrinol 10:322–337CrossRefPubMed
32.
go back to reference Sun T, Yi H, Yang C, Kishnani PS, Sun B (2016) Starch binding domain-containing protein 1 plays a dominant role in glycogen transport to lysosomes in liver. J Biol Chem 291:16479–16484CrossRefPubMedPubMedCentral Sun T, Yi H, Yang C, Kishnani PS, Sun B (2016) Starch binding domain-containing protein 1 plays a dominant role in glycogen transport to lysosomes in liver. J Biol Chem 291:16479–16484CrossRefPubMedPubMedCentral
Metadata
Title
Identification of Potential Gene Network Associated with HCV-Related Hepatocellular Carcinoma Using Microarray Analysis
Authors
Yang Cheng
Jian Ping
Jianjie Chen
Publication date
01-07-2018
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 3/2018
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-017-0273-8

Other articles of this Issue 3/2018

Pathology & Oncology Research 3/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine